How these pharmaceuticals may affect otolaryngology
Bypassing the Blood Brain Barrier Through the Nose
Mucosal grafting of arachnoid defects—commonly used for endoscopic skull base reconstruction—may represent a novel method to permanently bypass the blood-brain barrier for drug delivery
Personalized Care: Study highlights which patients would benefit from a second round of chemoradiation
Balancing the risks and benefits of concurrent reirradiation and chemotherapy for recurrent head and neck cancers is difficult for physicians at even the most experienced centers. Research recently published in Cancer, however, suggests that selection of patients who may benefit from this therapy should be based on the patient’s previous treatment and the amount of time that has elapsed since initial treatment…
EMR and Advertising: Strange Bedfellows?
Electronic medical records (EMR) are to health care professionals what world peace is to humanity-everyone wants it, but not everyone agrees how to go about it.
Drug Marketing: Different Impacts on Different Physicians
Pharmaceutical company representatives (PCRs) are as ubiquitous in otolaryngologists’ offices as seasonal allergies and ear infections.
Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
Recurrent respiratory papillomatosis (RRP) begins with a pretty small virus, relatively speaking, but it can lead to some pretty big problems for both the patient and the treating physician.
AMA’s Opt-Out Provision for Sale of Physician Prescribing Data Seen as First Step
Otolaryngologists agree with their fellow physicians who prescribe drugs-pharmaceutical companies have no business buying or using information on how and when they prescribe particular drugs, nor do they want to be confronted by pharmaceutical company representatives in their office about why they do or don’t prescribe that company’s products.
When It Comes to Drug Development, What Do Our Dollars Buy?
Two studies look at trends in the cost and length of time spent developing new pharmaceuticals
Prescription Drug Benefit Primer
This January, the Medicare Prescription Drug Benefit, created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), took effect.